22
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion

      research-article
      a , b , , 1 , c , ∗∗ , 1 , d , a , e , a , f , a , f , g , a , g , h , h , h , i , b , g , h , h , i , j , j , a , g , c , g , a , f , g , k , k , c , e , c , g , a , a , a , b , ∗∗∗
      Neurobiology of Aging
      Elsevier
      Frontotemporal dementia, Somatic instability, Amyotrophic lateral sclerosis

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          An expanded hexanucleotide repeat in the C9orf72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Although 0–30 hexanucleotide repeats are present in the general population, expansions >500 repeats are associated with C9ALS/FTD. Large C9ALS/FTD expansions share a common haplotype and whether these expansions derive from a single founder or occur more frequently on a predisposing haplotype is yet to be determined and is relevant to disease pathomechanisms. Furthermore, although cases carrying 50–200 repeats have been described, their role and the pathogenic threshold of the expansions remain to be identified and carry importance for diagnostics and genetic counseling. We present clinical and genetic data from a UK ALS cohort and report the detailed molecular study of an atypical somatically unstable expansion of 90 repeats. Our results across different tissues provide evidence for the pathogenicity of this repeat number by showing they can somatically expand in the central nervous system to the well characterized pathogenic range. Our results support the occurrence of multiple expansion events for C9ALS/FTD.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

          Several families have been reported with autosomal-dominant frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), genetically linked to chromosome 9p21. Here, we report an expansion of a noncoding GGGGCC hexanucleotide repeat in the gene C9ORF72 that is strongly associated with disease in a large FTD/ALS kindred, previously reported to be conclusively linked to chromosome 9p. This same repeat expansion was identified in the majority of our families with a combined FTD/ALS phenotype and TDP-43-based pathology. Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%). The repeat expansion leads to the loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, suggesting multiple disease mechanisms. Our findings indicate that repeat expansion in C9ORF72 is a major cause of both FTD and ALS. Copyright © 2011 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

            The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) locus contains one of the last major unidentified autosomal-dominant genes underlying these common neurodegenerative diseases. We have previously shown that a founder haplotype, covering the MOBKL2b, IFNK, and C9ORF72 genes, is present in the majority of cases linked to this region. Here we show that there is a large hexanucleotide (GGGGCC) repeat expansion in the first intron of C9ORF72 on the affected haplotype. This repeat expansion segregates perfectly with disease in the Finnish population, underlying 46.0% of familial ALS and 21.1% of sporadic ALS in that population. Taken together with the D90A SOD1 mutation, 87% of familial ALS in Finland is now explained by a simple monogenic cause. The repeat expansion is also present in one-third of familial ALS cases of outbred European descent, making it the most common genetic cause of these fatal neurodegenerative diseases identified to date. Copyright © 2011 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

              Breakthrough discoveries identifying common genetic causes for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have transformed our view of these disorders. They share unexpectedly similar signatures, including dysregulation in common molecular players including TDP-43, FUS/TLS, ubiquilin-2, VCP, and expanded hexanucleotide repeats within the C9ORF72 gene. Dysfunction in RNA processing and protein homeostasis is an emerging theme. We present the case here that these two processes are intimately linked, with disease-initiated perturbation of either leading to further deviation of both protein and RNA homeostasis through a feedforward loop including cell-to-cell prion-like spread that may represent the mechanism for relentless disease progression. Copyright © 2013 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Neurobiol Aging
                Neurobiol. Aging
                Neurobiology of Aging
                Elsevier
                0197-4580
                1558-1497
                1 January 2015
                January 2015
                : 36
                : 1
                : 546.e1-546.e7
                Affiliations
                [a ]Department of Neurodegenerative Disease, University College London, Queen Square, London, UK
                [b ]MRC Centre for Neuromuscular Diseases, University College London, Queen Square, London, UK
                [c ]Neurogenetics Unit, Queen Square, London, UK
                [d ]NeuroResource, Institute of Neurology, University College London, Queen Square, London, UK
                [e ]Queen Square Brain Bank for Neurological Disorders, University College London, Queen Square, London, UK
                [f ]MRC Prion Unit, University College London, Queen Square, London, UK
                [g ]Department of Molecular Neuroscience, University College London, Queen Square, London, UK
                [h ]National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
                [i ]Centre for Neuroscience & Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK
                [j ]Sobell Department of Motor Neuroscience and Movement Disorders, University College London, Queen Square, London, UK
                [k ]Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institutes of Health, National Institute on Aging, Bethesda, MD, USA
                Author notes
                []Corresponding author at: Department of Neurodegenerative Disease, University College London, Queen Square WC1N 3BG, London, UK. Tel.: +44 2034484448; fax: +44 2034484447. p.fratta@ 123456ucl.ac.uk
                [∗∗ ]Alternate corresponding author at: Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK. Tel.: +44 2034484250; fax: +442074190948. James.Polke@ 123456uclh.nhs.uk
                [∗∗∗ ]Alternate corresponding author at: Department of Neurodegenerative Disease, University College London, Queen Square WC1N 3BG, London, UK. Tel.: +44 2034484448; fax: +44 2034484447. e.fisher@ 123456prion.ucl.ac.uk
                [1]

                These authors contributed equally to the manuscript.

                Article
                S0197-4580(14)00506-5
                10.1016/j.neurobiolaging.2014.07.037
                4270445
                25179228
                a4c28d40-1b02-4523-8852-1adec9feba74
                © 2015 The Authors
                History
                : 24 July 2014
                : 27 July 2014
                Categories
                Genetic Report Abstract

                Neurosciences
                frontotemporal dementia,somatic instability,amyotrophic lateral sclerosis
                Neurosciences
                frontotemporal dementia, somatic instability, amyotrophic lateral sclerosis

                Comments

                Comment on this article